header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-FISH-150901-1278
Fish name: adgrg6st49/st49
Genotype: adgrg6st49/st49
Targeting Reagent: none
HUMAN DISEASE MODELED by adgrg6st49/st49
No data available
GENE EXPRESSION
Gene expression in adgrg6st49/st49
RNA expression
Expressed Gene Structure Conditions Figures
adgrg6 standard conditions Fig. S5 from Monk et al., 2009
egr2b standard conditions Fig. 2 with image from Glenn et al., 2013
Fig. 2Fig. 4 from Monk et al., 2009
chemical treatment: forskolin Fig. 2 with image from Glenn et al., 2013
Fig. 4 from Monk et al., 2009
erbb3b standard conditions Fig. S8 from Monk et al., 2009
mbpa standard conditions Fig. 2 with imageFig. 5 with imageFig. 7 with image from Glenn et al., 2013
Fig. 4Fig. S1 from Monk et al., 2009
chemical treatment: forskolin Fig. 2 with image from Glenn et al., 2013
Fig. 4 from Monk et al., 2009
nrg1 standard conditions Fig. S8 from Monk et al., 2009
pou3f1 standard conditions Fig. 2Fig. 4 from Monk et al., 2009
chemical treatment: forskolin Fig. 4 from Monk et al., 2009
sox10 standard conditions Fig. 2 with image from Glenn et al., 2013
Fig. 2 from Monk et al., 2009
chemical treatment: forskolin Fig. 2 with image from Glenn et al., 2013
Protein expression
Antibody Antigen Genes Structure Conditions Figures
Ab1-mbp control Fig. S8 from Küffer et al., 2016
Reporter gene expression No data available
PHENOTYPE
Phenotype in adgrg6st49/st49
Phenotype Conditions Figures
inner ear edematous, abnormal standard conditions Fig. S4 with image from Patra et al., 2013
inner ear increased size, abnormal standard conditions Fig. 1 with image from Sanchez et al., 2017
Fig. S4 with image from Patra et al., 2013
Fig. S2 from Monk et al., 2009
inner ear swollen, abnormal standard conditions Fig. 1 with image from Sanchez et al., 2017
myelination in peripheral nervous system decreased occurrence, abnormal standard conditions Fig. 5 with image from Glenn et al., 2013
myelination of posterior lateral line nerve axons arrested, abnormal control Fig. 1 with imageFig. 2 with image from Glenn et al., 2013
myelination of posterior lateral line nerve axons decreased occurrence, abnormal chemical treatment: forskolin Fig. 1 with imageFig. 2 with image from Glenn et al., 2013
nerve compact myelin absent, normal standard conditions Fig. S9 from Monk et al., 2009
pericardium structure, normal standard conditions Fig. S4 with image from Patra et al., 2013
posterior lateral line myelination in peripheral nervous system arrested, abnormal standard conditions Fig. 1 with imageFig. 2 with imageFig. 7 with image from Glenn et al., 2013
posterior lateral line myelination in peripheral nervous system decreased occurrence, abnormal chemical treatment: forskolin Fig. 1 with imageFig. 2 with image from Glenn et al., 2013
posterior lateral line nerve ab1-mbp labeling decreased amount, abnormal control Fig. S8 from Küffer et al., 2016
posterior lateral line nerve decreased thickness, abnormal standard conditions Fig. S9 from Monk et al., 2009
posterior lateral line nerve compact myelin absent, abnormal standard conditions Fig. 3Fig. S3 from Monk et al., 2009
posterior lateral line nerve myelin sheath decreased thickness, abnormal standard conditions Fig. 3 from Monk et al., 2009
posterior lateral line nerve myelin sheath morphology, abnormal standard conditions Fig. 2Fig. 4 from Monk et al., 2009
whole organism morphology, normal standard conditions Fig. S2 from Monk et al., 2009

CITATIONS  (10)